Ad is loading...
MKTRX
Price
$20.74
Change
-$0.12 (-0.58%)
Updated
Nov 15 closing price
RCEEX
Price
$71.49
Change
-$0.32 (-0.45%)
Updated
Nov 15 closing price
Ad is loading...

MKTRX vs RCEEX

Header iconMKTRX vs RCEEX Comparison
Open Charts MKTRX vs RCEEXBanner chart's image
NYLI Income Builder
Price$20.74
Change-$0.12 (-0.58%)
VolumeN/A
CapitalizationN/A
American Funds Capital Income Bldr R2E
Price$71.49
Change-$0.32 (-0.45%)
VolumeN/A
CapitalizationN/A
MKTRX vs RCEEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MKTRX vs. RCEEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKTRX is a Sell and RCEEX is a Buy.

FUNDAMENTALS
Fundamentals
RCEEX has more cash in the bank: 107B vs. MKTRX (1.05B). RCEEX pays higher dividends than MKTRX: RCEEX (2.85) vs MKTRX (1.91). MKTRX was incepted earlier than RCEEX: MKTRX (37 years) vs RCEEX (10 years). RCEEX is a more actively managed with annual turnover of: 106.00 vs. MKTRX (56.00). RCEEX has a lower initial minimum investment than MKTRX: RCEEX (250) vs MKTRX (1000). MKTRX annual gain was more profitable for investors over the last year : 19.27 vs. RCEEX (17.34). RCEEX return over 5 years is better than : 25.26 vs. MKTRX (10.12).
MKTRXRCEEXMKTRX / RCEEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years10 years-
Gain YTD11.54310.184113%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.05B107B1%
Annual Yield % from dividends1.912.8567%
Returns for 1 year19.2717.34111%
Returns for 3 years-0.9410.58-9%
Returns for 5 years10.1225.2640%
Returns for 10 years13.8832.4343%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TXNM46.300.49
+1.07%
TXNM Energy Inc
SBSI35.890.21
+0.59%
Southside Bancshares Inc
EML27.50-0.65
-2.31%
Eastern Company
CELH25.66-1.27
-4.72%
Celsius Holdings
CARA0.31-0.02
-5.04%
Cara Therapeutics